Full View

Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis

B Wang, Y Huang - Oncoimmunology, 2020 - Taylor & Francis
Background This study was designed to investigate whether COVID-19 patients with
recently received immunotherapy or other anti-cancer treatments had more severe …
被引用次数：32 相关文章

Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis

B Wang, Y Huang - Oncoimmunology, 2020 - pubmed.ncbi.nlm.nih.gov
Background This study was designed to investigate whether COVID-19 patients with
recently received immunotherapy or other anti-cancer treatments had more severe …
[HTML] nih.gov

[HTML][HTML] Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta …

B Wang, Y Huang - Oncoimmunology, 2020 - ncbi.nlm.nih.gov
Background This study was designed to investigate whether COVID-19 patients with
recently received immunotherapy or other anti-cancer treatments had more severe …

Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.

B Wang, Y Huang - Oncoimmunology, 2020 - europepmc.org
Background This study was designed to investigate whether COVID-19 patients with
recently received immunotherapy or other anti-cancer treatments had more severe …